Parkinson’s Disease

What to Expect When You’re Newly Diagnosed with Parkinson’s

Parkinson’s disease is the second most common neurodegenerative disease in the United States. According to the National Institute of Neurological Disorders and Stroke, 500,000 Americans have a Parkinson’s disease diagnosis. Receiving this diagnosis can leave you unsure of what to expect or what steps to take. Learn more about what to expect when you're newly diagnosed…

Could Fat Be the Secret to Regenerative Medicine Treatments for Parkinson’s Disease?

For several decades, there has been extensive research into how regenerative medicine, also known as regenerative medicine, can help patients suffering from central nervous system disorders. One of the most heavily researched conditions has been Parkinson’s disease. Patients who struggle with Parkinson’s understand how severe their symptoms can be and how rapidly the disease can progress.…

What Are the Current Treatments for Parkinson’s Disease?

Treating the neurodegenerative disorder Parkinson’s disease can be incredibly challenging. Since the condition’s progression varies widely, there is no standard treatment. Ideally, patients work with their healthcare provider to create a treatment plan tailored to their symptoms. Here we will discuss the current treatments for Parkinson's Disease. Most treatment plans include a multipronged approach, combining exercise,…

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson’s Disease

Research has shown neuroinflammation to have a significant role in the pathogenesis of Parkinson’s disease (PD). Much of this same research has also demonstrated mesenchymal stem cells (MSCs), and specifically, allogeneic bone marrow-derived MSCs, can be effectively used as an immunomodulatory therapy for the potential treatment of PD. The goal of Schiess et al.’s study…

Mesenchymal Regenerative Medicine for Parkinson’s Disease

Regenerative medicine, also known as regenerative medicine, is emerging as a viable treatment for Parkinson’s disease as clinical trials move through the FDA approval process. Patients in clinical trials see positive results from mesenchymal regenerative medicine for Parkinson's Disease.  What Is Parkinson’s Disease?  Parkinson’s disease is a progressive, neurodegenerative condition. It occurs when dopamine-producing brain…

The Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease

Parkinson’s disease (PD) is a debilitating neurodegenerative disorder that currently affects nearly 6 million people worldwide and is currently the second most common neurological condition, behind only Alzheimer’s. Although the exact cause of PD remains unclear, the condition is characterized by the gradual loss of nerve cells in the brain responsible for producing the neurotransmitter…

Steps for Anyone Newly Diagnosed with Parkinson’s Disease

Receiving a diagnosis of any chronic condition can be overwhelming, and Parkinson’s disease (PD) is certainly no exception. While it’s normal to feel a range of emotions after you’re first diagnosed, you might also feel a sense of relief to have a concrete diagnosis. And, with an accurate diagnosis, you can also begin your pursuit…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.